Many people know thyroid cancer as a cancer type with a relatively good prognosis, but the disease still has profound effects on patients and survivors, writes thyroid cancer survivor Carly Flumer.

by Carly Flumer

The Cancer Today editorial staff selects some of the most impactful and informative reporting and essays of 2019.

by Cancer Today Staff

The winter 2019/2020 issue of Cancer Today tells the stories of people working to improve privacy protections for patients seeking support online, expand access to genetic testing and boost the efficacy of immunotherapy to benefit more patients.

by Kevin McLaughlin

Letting children know they might have a mutation that increases their risk for cancer can be a challenge for patients. Experts stress there is no right or wrong way to share the information.

by Marci A. Landsmann

Companies that offer disability insurance may monitor patients' social media accounts to determine if they qualify for the benefits being received.

by Kate Yandell

Art therapist and licensed clinical professional counselor Jacqueline Carmody describes how a unique art therapy program helps people affected by cancer.

by Bradley Jones

Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.

by Marci A. Landsmann

Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development.

by Marci A. Landsmann

Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.

by Marci A. Landsmann

Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.

by Ashley P. Taylor